Combining CRISPR screening with single-cell RNA sequencing, Vienna-based Aelian Biotechnology has developed a new discovery tool for functional genomics. It enables biotech and pharma companies to ...
The agreement grants Jumpcode access to ERS' CRISPR/Cas9 patent portfolio, empowering the company to advance the sensitivity and efficiency of next-generation sequencing (NGS) and expand ...
Hosted on MSN1mon
CRISPR-Cas9 Off-Target Effects: Challenges and SolutionsThe CRISPR-Cas (Clustered Regularly Interspaced ... For example, in contrast to SpCas9, which uses a relatively common PAM sequence, utilization of the SaCas9 produced from Staphylococcus aureus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results